Contact information
stefan.neubauer@cardiov.ox.ac.uk
01865 226829 (PA)
Laura Bourne
laura.bourne@cardiov.ox.ac.uk
Websites
-
OCMR
Clinical facility
Stefan Neubauer
FMedSci FRCP
Professor of Cardiovascular Medicine
- Honorary Consultant Cardiologist
- Head of the Division of Cardiovascular Medicine
- Director, University of Oxford Centre Clinical Magnetic Resonance Research (OCMR)
Phenotyping of cardiovascular and multiorgan disease with advanced non-invasive imaging methods
Stefan Neubauer is a Professor of Cardiovascular Medicine, Head of the Division of Cardiovascular Medicine and Director of the Oxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, John Radcliffe Hospital, United Kingdom.
Professor Neubauer’s work over the past 35 years has been devoted to the development and application of Cardiovascular Magnetic Resonance (CMR) imaging and spectroscopy, and, in recent years, also to the development of novel liver and multiorgan MR imaging as well as novel coronary CT imaging.
He has attracted over £180M in research funding, has published >580 original research articles and currently leads a group of ~60 co-workers. He has supervised over 50 PhD/MD students, who have won >25 young investigator awards.
Editorial positions and contributions to scientific bodies include:
- Society for Cardiovascular Magnetic Resonance (President 2006-2007)
- Chairman of the British Society of Cardiovascular Magnetic Resonance (2008-2010)
- International Associate Editor of the European Heart Journal (2010-2020)
- Associate Editor of the Journal of Cardiovascular Magnetic Resonance.
Awards and Honours include:
- American Heart Association Paul Dudley White International Lectureship Award 2005
- British Cardiovascular Society Thomas Lewis Lecture 2008
- National Institute for Health Research Senior Investigator Award 2010
- the European Magnetic Resonance Award 2010
- the SCMR Gold Medal 2013
Professor Neubauer is a fellow of the UK Academy of Medical Sciences. He has been the leader of the Imaging Theme for the Oxford NIHR Biomedical Research Centre since 2017. He is also a founder, and was (2012-2019) CMO of Perspectum, a biomedical imaging biotech company, and is a founder and NED of Caristo Diagnostics (since 2018), a cardiac CT spinout company.
Recent publications
-
Inflammatory cardiovascular events and coronary artery disease – Authors' reply
Chan K. et al, (2025), The Lancet, 405, 545 - 546
-
Myocardial ischaemia following COVID-19: a cardiovascular magnetic resonance study.
Arnold JR. et al, (2025), Int J Cardiovasc Imaging, 41, 247 - 256
-
Multiparametric cardiovascular magnetic resonance evaluation of myocardial perfusion, oxygenation, and energetics in hypertrophic cardiomyopathy following cardiac myosin inhibitor therapy.
Finnigan LEM. et al, (2025), Eur Heart J Cardiovasc Imaging, 26
-
Myocardial disarray and fibrosis across hypertrophic cardiomyopathy stages associate with ECG markers of arrhythmic risk.
Ashkir Z. et al, (2025), Eur Heart J Cardiovasc Imaging, 26, 218 - 228
-
Relationship between left ventricular shape and cardiovascular risk factors: comparison between the Multi-Ethnic Study of Atherosclerosis and UK Biobank.
Suinesiaputra A. et al, (2025), Heart
-
Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations.
Rua C. et al, (2024), Brain, 147, 4121 - 4130
-
1H and 31P MR Spectroscopy to Assess Muscle Mitochondrial Dysfunction in Long COVID
Finnigan LEM. et al, (2024), Radiology, 313
-
1H and 31P MR Spectroscopy to Assess Muscle Mitochondrial Dysfunction in Long COVID.
Finnigan LEM. et al, (2024), Radiology, 313
-
Etiology and Phenotypes of Cardiomyopathy in Southern Africa: The IMHOTEP Multicenter Pilot Study.
Kraus SM. et al, (2024), JACC Adv, 3
-
Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic Cardiomyopathy.
Tahir UA. et al, (2024), Circ Heart Fail, 17